Malaria Vaccines Market Insights, Opportunity Analysis, and Industry Forecast 2024 - 2027
- Get link
- X
- Other Apps
Malaria Vaccines Market |
According to World Health Organization statistics, about
half of the world's population is at risk of malaria (WHO). As a result,
numerous healthcare organisations have been more interested in solving this
serious problem. The Melinda Gates Foundation and PATH, two global non-profit
organisations, are trying to develop malaria prevention techniques and save the
lives of many people in malaria-affected areas. Because Africa accounts for 90%
of malaria occurrences, the launch of GlaxoSmithKline plc's first malaria
vaccine is aimed primarily at this continent. Mosquirix was approved by the
European Union in 2015 and is currently being tested in Africa as part of a
pilot project.
Insecticide-treated mosquito nets and indoor insecticide
spraying are used in Africa to combat malarial vectors. Between 2010 and 2015,
the use of insecticide-treated mosquito nets in Africa climbed by 80%. (WHO).
Furthermore, a variety of mosquito repellent items (patches, lotions, coils,
mats, liquids, and so on) are sold all over the world. Furthermore, non-profit
organisations give low-cost or even free treatment to Africa's malaria-affected
people. GSK has also committed to selling the vaccinations at a substantially
cheaper price, foregoing its large profit margins in order to help worldwide
malaria eradication efforts. Furthermore, the malaria
vaccines market is primed for significant growth in the near future,
with new malaria vaccines in the pipeline.
Increasing
accessibility and government support to contribute towards the malaria vaccines
market growth
In 2015, the WHO published a Global Technical Strategy for
Malaria 2016-2030 (GTS) with specific objectives, one of which is to eradicate
malaria in at least ten countries. In India, Drug Distribution Centers (DDCs)
and Fever Treatment Depots (FTDs) have been developed in rural regions to
provide convenient access to anti-malarial medications. Malaria cases in India
have decreased from 2.03 million in 2010 to 1.1 million in 2015. This is thanks
to regular monitoring and surveillance by various government programmes.
Malaria vaccines market expansion would be fueled by support from national and
global initiatives throughout the projected period.
- Get link
- X
- Other Apps
Comments
Post a Comment